NDATF.US nDatalyze Corp
- Market cap
- USD 6.08M
- P/E
- -
- P/B
- 14.24x
- ROE
- -88.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Aug 2026.
Is NDATF.US undervalued?
Graham numberThe Graham number of nDatalyze Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
nDatalyze Corp fundamental analysis
No fundamental analysis for nDatalyze Corp yet.
nDatalyze Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About nDatalyze Corp
nDatalyze Corp. provides technologically based solutions related to applying machine learning to a records database to predict probable mental health conditions. The company provides Sigmund, a machine-learning-based online mental health application for the mental health system, such as misdiagnosis and mis prescription. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is…
Full company profilenDatalyze Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
nDatalyze Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | 162K | 531K | 663K | 425K | 171K | 96.3K | 1.71K | 0.00 | 0.00 |
| Gross Profit | - | 107K | 317K | 377K | 230K | 44.8K | 67.4K | 1.55K | 0.00 | - |
| Operating Income | -302K | -236K | -45.4K | -587K | -927K | -942K | -455K | -638K | -198K | -200K |
| EBITDA | - | -253K | -25.7K | -689K | -1.17M | -1.23M | -429K | -636K | -176K | -195K |
| Net Income | -304K | -257K | -36.6K | -699K | -1.17M | -1.23M | -156K | -554K | -212K | -198K |
| EPS | -0.02 | -0.01 | 0.00 | -0.03 | -0.03 | -0.03 | 0.00 | -0.01 | -0.01 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 328K | 269K | 674K | 873K | 1.71M | 862K | 878K | 561K | 342K | 242K |
| Total Liabilities | 3.54K | 28.1K | 36.9K | 71.9K | 81.4K | 289K | 38.3K | 24.5K | 18.1K | 16.4K |
| Shareholders' Equity | 325K | 241K | 637K | 801K | 1.63M | 573K | 840K | 536K | 324K | 225K |
| Cash & Short-term Investments | 228K | 143K | 594K | 781K | 1.60M | 743K | 794K | 523K | 331K | 228K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -261K | -216K | 92.1K | 20.7K | -1.13M | -1.02M | -217K | -466K | -192K | -207K |
| Capital Expenditure | 948.00 | 6.12K | 1.76K | 1.84K | 13.9K | 4.39K | 4.17K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -261K | -223K | 90.4K | 18.9K | -1.14M | -1.03M | -222K | -466K | -192K | -207K |
| Ratios | ||||||||||
| ROE | -93.6% | -106.6% | -5.7% | -87.2% | -72.0% | -215.1% | -18.5% | -103.4% | -65.4% | -88.0% |
| ROA | -92.6% | -95.5% | -5.4% | -80.0% | -68.6% | -142.9% | -17.7% | -98.9% | -61.9% | -82.0% |
| Net Profit Margin | - | -158.2% | -6.9% | -105.4% | -276.2% | -719.6% | -161.5% | -32,349.8% | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
nDatalyze Corp dividends
nDatalyze Corp has not paid dividends in the last 9 fiscal years.
Who owns nDatalyze Corp
- Insiders 21.72%
- Institutions 0.00%
- Public & others 78.28%
- Shares outstanding 41.3M
- Free float 29.1M
nDatalyze Corp company profile
- Company name
- nDatalyze Corp
- Ticker
- NDATF.US
- ISIN
- CA63948H1055
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 1
- Fiscal year end
- February
- Address
- 707 ? 7th Ave. SW, Calgary, AB, Canada, T2P 3H6
- Phone
- 403-689-3901
- Website
- ndatalyze.com
About nDatalyze Corp
nDatalyze Corp. provides technologically based solutions related to applying machine learning to a records database to predict probable mental health conditions. The company provides Sigmund, a machine-learning-based online mental health application for the mental health system, such as misdiagnosis and mis prescription. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada.
nDatalyze Corp management
3- Mr. James Morris DurwardChief Technical Officer, President, CEO, Corporate Secretary & Director · born 1955
- Mr. Dwayne A. Vinck C.A., C.P.A.Chief Financial Officer · born 1965
- Dr. Keith CourtneyChief Psychiatric Officer